↓ Skip to main content

Dove Medical Press

Everolimus-eluting stents in interventional cardiology

Overview of attention for article published in Vascular Health and Risk Management, June 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
34 Mendeley
Title
Everolimus-eluting stents in interventional cardiology
Published in
Vascular Health and Risk Management, June 2012
DOI 10.2147/vhrm.s23388
Pubmed ID
Authors

Jacob C Townsend, Phillip Rideout, Daniel H Steinberg

Abstract

Bare metal stents have a proven safety record, but limited long-term efficacy due to in-stent restenosis. First-generation drug-eluting stents successfully countered the restenosis rate, but were hampered by concerns about their long-term safety. Second generation drug-eluting stents have combined the low restenosis rate of the first generation with improved long-term safety. We review the evolution of drug-eluting stents with a focus on the safety, efficacy, and unique characteristics of everolimus-eluting stents.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 26%
Researcher 7 21%
Other 4 12%
Student > Ph. D. Student 3 9%
Student > Master 2 6%
Other 2 6%
Unknown 7 21%
Readers by discipline Count As %
Medicine and Dentistry 11 32%
Biochemistry, Genetics and Molecular Biology 4 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Engineering 2 6%
Mathematics 1 3%
Other 5 15%
Unknown 8 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2022.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Vascular Health and Risk Management
#301
of 804 outputs
Outputs of similar age
#60,379
of 179,215 outputs
Outputs of similar age from Vascular Health and Risk Management
#6
of 15 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 804 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,215 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.